Matches in Wikidata for { <http://www.wikidata.org/entity/Q64354863> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q64354863 description "assaig clínic" @default.
- Q64354863 description "clinical trial" @default.
- Q64354863 description "clinical trial" @default.
- Q64354863 description "clinical trial" @default.
- Q64354863 description "clinical trial" @default.
- Q64354863 description "ensaio clínico" @default.
- Q64354863 description "ensayo clínico" @default.
- Q64354863 description "ensayu clínicu" @default.
- Q64354863 description "essai clinique" @default.
- Q64354863 description "klinisch onderzoek" @default.
- Q64354863 description "клінічне випробування" @default.
- Q64354863 name "Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients" @default.
- Q64354863 type Item @default.
- Q64354863 label "Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients" @default.
- Q64354863 prefLabel "Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients" @default.
- Q64354863 P1050 Q64354863-3499715E-869A-44EB-9C13-40FB639A323C @default.
- Q64354863 P1050 Q64354863-F3515B97-610E-467B-81A8-FD15798BBBED @default.
- Q64354863 P1132 Q64354863-219008B0-AD1E-4B45-B3D2-1159F06F9759 @default.
- Q64354863 P1476 Q64354863-04B480C0-9BFA-42A4-BEA7-95244AB512EA @default.
- Q64354863 P17 Q64354863-8BD57499-319E-4A22-B462-689A3418CCCA @default.
- Q64354863 P2899 Q64354863-46E9CE49-87DC-4301-AC7C-7F632C6FAC7E @default.
- Q64354863 P3098 Q64354863-832D8856-C63D-4F62-A3BD-451FC92015A7 @default.
- Q64354863 P31 Q64354863-59AF4FDA-5658-4B65-95DB-AF301BE87B5B @default.
- Q64354863 P4844 Q64354863-CE94FA7C-A9D0-488B-AB66-F3B7A41D7013 @default.
- Q64354863 P580 Q64354863-8907E49A-031D-4C29-A9B9-3FBCDBE57701 @default.
- Q64354863 P582 Q64354863-0A52E7EA-E25A-4A46-A4BA-6FF5B71D6821 @default.
- Q64354863 P6099 Q64354863-095DBCD2-8135-4922-9D6C-011C7DA98893 @default.
- Q64354863 P6099 Q64354863-687E5186-A5BC-49E7-887E-41FF5B88409A @default.
- Q64354863 P6153 Q64354863-2942D5C1-2B82-45AE-A328-A7A977D5D019 @default.
- Q64354863 P6153 Q64354863-618BFE35-7ED4-4AF1-9482-0E6A61187F70 @default.
- Q64354863 P6153 Q64354863-AF255725-E71F-42B9-88C5-1B6BD995BF4C @default.
- Q64354863 P8363 Q64354863-E8CBA920-6C1D-4533-BA2B-23B40BDF18F2 @default.
- Q64354863 P1050 Q33525 @default.
- Q64354863 P1050 Q5958765 @default.
- Q64354863 P1132 "+112" @default.
- Q64354863 P1476 "Phase 1b/II Trial of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies (Phase Ib) and Small Cell Lung Cancer Patients (Phase II) Who Have Progressed on Prior Platinum-based Chemotherapy" @default.
- Q64354863 P17 Q30 @default.
- Q64354863 P2899 "+18" @default.
- Q64354863 P3098 "NCT01941316" @default.
- Q64354863 P31 Q30612 @default.
- Q64354863 P4844 Q412197 @default.
- Q64354863 P580 "2013-11-01T00:00:00Z" @default.
- Q64354863 P582 "2018-12-01T00:00:00Z" @default.
- Q64354863 P6099 Q42824440 @default.
- Q64354863 P6099 Q5452194 @default.
- Q64354863 P6153 Q1052562 @default.
- Q64354863 P6153 Q2725999 @default.
- Q64354863 P6153 Q7972509 @default.
- Q64354863 P8363 Q78089383 @default.